[Ferritin (tumor marker) in patients with laryngeal cancer and precancerous conditions].
Evaluation of the ferritin as a neoplasm marker was performed in laryngeal cancer patients. In 35 laryngeal cancer patients and in 21 laryngeal leucoplakia patients the ferritin serum level and the blastic transformation of leucocytes were tested. In both groups the high ferritin level was discovered. It is the sign of low specificity of ferritin as a neoplasm marker. There was no correlation between the ferritin serum level and the degree of the blastic changes of leucocytes.
Tarchalska-Kryńska
B
B
Zakładu Farmakologii Doświadczalnej i Klinicznej AM, Warszawie.
Sawicka
B
B
Zawisza
E
E
Andrzejewski
A
A
D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood*; D005293:Ferritins / Q000097:blood*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000097:blood*; D007971:Leukoplakia / Q000097:blood*
D014408:Biomarkers, Tumor; D005293:Ferritins
Ferrytyna (marker nowotworowy) u chorych na raka krtani w stanach przedrakowych.